| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.5 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.5 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |